A Win For Menlo Therapeutics Inc.

Fri 06 Mar 20 at 05:30 PM

Menlo Therapeutics Inc. (MNLO:NASDAQ) jumped higher at $4.15, representing a gain of 26.9%. The stock appeared on our News Catalysts scanner on Tue 03 Mar 20 at 06:04 PM in the 'EARNINGS' category. From Thu 20 Feb 20, the stock recorded 30.00% Up Days and 27.27% Green Days

About Menlo Therapeutics Inc. (MNLO:NASDAQ)

Menlo Therapeutics Inc is a biopharmaceutical company focused on the development and commercialization of serlopitant for the treatment of pruritus, associated with dermatologic conditions such as atopic dermatitis, psoriasis and prurigo nodularis.

Top 10 Gainers:

Spherix Incorporated (SPEX:NASDAQ), 130.99%
Digirad Corporation (DRAD:NASDAQ), 114.42%
Tocagen Inc. (TOCA:NASDAQ), 56.52%
Enzo Biochem, Inc. (ENZ:NYSE), 50.44%
Inovio Pharmaceuticals, Inc. (INO:NASDAQ), 43.78%
NanoViricides, Inc. (NNVC:NYSEMKT), 38.49%
Menlo Therapeutics Inc. (MNLO:NASDAQ), 26.91%
TEGNA Inc. (TGNA:NYSE), 26.49%
Cleveland BioLabs, Inc. (CBLI:NASDAQ), 24.57%
iFresh Inc. (IFMK:NASDAQ), 24.54%